Skip to main content
Fig. 1 | Health and Quality of Life Outcomes

Fig. 1

From: Quality of life after low-dose rate-brachytherapy for prostate carcinoma – long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series

Fig. 1

EORTC-QLQ-C30 scales after long-term follow-up in patients treated with brachytherapy compared to the German reference population. Age stratification according to Schwarz and Hinz [18], 1a) Population ≥ 70 years old and 1b) Population 60–69 years old. Higher function values indicate better function. Higher symptom values indicate worse symptoms. Bars represent mean values. Lines show standard deviations

Back to article page